Personalized cardiology and precision medicine are revolutionizing heart disease treatment by tailoring care to each individual based on their unique genetic makeup, lifestyle, and environment. This approach allows cardiologists to select the most effective therapies for patients, increasing the likelihood of successful outcomes and minimizing adverse effects. By utilizing advanced diagnostic tools, such as genetic testing and imaging, personalized cardiology helps identify risk factors early, enabling timely interventions. In the realm of precision medicine, therapies are designed to target specific pathways involved in the patient’s condition, ensuring more efficient treatment and improving the overall prognosis for heart disease patients.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation